Skip to main content

Find Clinical Trials

Home
Conditions
Resectable Carcinoma

Clinical trial condition

Resectable Carcinoma

Explore clinical trials studying Resectable Carcinoma. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Resectable Carcinoma trial results

Recruiting

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer

NCT05802407

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Completed

Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT)

NCT04736485

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer by AJCC V8 Stage, +7 more
Locations: CHU Besançon Besançon, France

Centre François Baclesse Caen, France

Centre Georges Francois Leclerc Dijon, France

Chru Lille Lille, France

View all 13 locations

View Trial Details

Active, Not Recruiting

Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy

NCT04554771

Conditions: Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Oesophageal Adenocarcinoma, +1 more
Locations: Academic Medical Center, Medical Oncology Amsterdam, Netherlands

View Trial Details